skip to main content

Treatment Information

To appreciate why the expertise of an institution like the University of Michigan Rogel Cancer Center is so critical to success in BMT, it's important to understand what's involved in the treatment.

Inside this section

What illnesses are treated with blood or marrow transplantation?

What is bone marrow?

What are stem cells?

What is a bone marrow transplant?

Appointments, Referrals and Physicians

The information on this page has moved. To make an appointment call 734-647-8902. Or, visit our Appointment Request page.

Adult Bone Marrow Transplant and Acute Leukemia Clinic

Combining blood cancer diagnosis and bone marrow transplant treatment in a state of the art facility. Contact us at 734-647-8902. Healthcare professionals, contact M-LINE: 800-962-3555

Bone Marrow Transplant (BMT) Program

The Blood and Marrow Transplantation Program is where compassionate care, multidisciplinary collaboration, and the latest research innovations come together to help severely ill patients whose conditions require that they undergo this highly specialized treatment.

Advanced Cancer

Patients and families dealing with advanced cancer have special needs and concerns. Patient and Family Support Services offers the following resources:

Survivorship - After Treatment

The information on this page has moved. Please visit the Survivorship page.

Support Services

Helping You and Your Family Adjust to Life with Cancer

Thursday Wellness: Noon - 1p.m.

At Diagnosis

The following services are available to you at the time of your diagnosis and are intended to help you understand your cancer, decide the best course of treatment, cope with the changes to your personal life and/or financial situation and familiarize yourself with the cancer center building in particular and the U-M health campus in general.

Researchers ID promising pancreatic cancer screening marker

Researchers at the University of Michigan Rogel Cancer Center have identified a protein that shows distinct changes in structure between pancreatic cancer, non-cancerous diseases and normal blood serum. The protein also changes from early stage pancreatic cancer to advanced disease.

Pages